BIB Ultra NASDAQ Biotechnology (2x) ETF

Seeks daily investment results before fees and expenses that correspond to twice (200%) the daily performance of the NASDAQ Biotechnology Index.The Index contains securities of NASDAQ-listed companies, including ADRs of non-US companies, classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria.

$58.12  -2.63 (-4.33%)
As of 08/17/2022 15:59:47 EST     IEX book   CBOE book


ETF Information
Sponsor:     ProShares
Category1:  US Equity
Category2:  Single industry
Category3:  Biotechnology
Morningstar category:  Trading--Leveraged Equity
Leverage factor:  2.00
Inception date:  04/06/2010
Index tracking method: Passive replication
Current yield:  0.00%
Historical average yield:  0.35%
Market cap:  $120,622,000
Average volume:  45,027
Fees:     0.9500%

Index Information
NASDAQ Biotechnology Index
Index symbol:  NBI
Provider:   NASDAQ OMX
Index weighting:   Market capitalization
Index inception date:  11/01/1993
Backtesting data exists:   No
Number of holdings:  159  (as of 11/28/2017)

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy